Search Results for: cryo-cell

Vice tackles dicey Cryo-Cell Duke mega-million peds clinic plan

Cord-blood-autism

When I first learned about the multi-$10 million cord cell clinic deal between Duke and Cryo-Cell I couldn’t believe what I was reading. Duke’s involved in this? The problem: marketing unproven cells for kids Yes, this wasn’t some stem cell clinic operating out of a strip mall seeking to make big money off of injecting …

Vice tackles dicey Cryo-Cell Duke mega-million peds clinic plan Read More »

FDA should freeze Duke EAP & probe $58 million Cryo-Cell deal linked to it

cryo cell infusion clinic marketing

I recently found concerning SEC filings from the biotech Cryo-Cell about a deal it has with a Duke team for infusions of children with unproven umbilical cord cells. This turns out to be a $58 million deal. It relates in a major way to a Duke compassionate use or expanded access program (EAP) that already had raised …

FDA should freeze Duke EAP & probe $58 million Cryo-Cell deal linked to it Read More »

Duke & Cryo-Cell plan big stem cell clinic for kids for unproven infusions

cryo cell duke stem cells autism cp

Duke Professor Joanne Kurtzberg’s clinical work on umbilical cord blood for autism and cerebral palsy (CP) involves a partnership with a publicly-traded cord blood banking firm called Cryo-Cell. Kurtzberg is also the Medical Director at the firm. In addition they have intellectual property in this area. The Duke team’s efforts, including those done outside of …

Duke & Cryo-Cell plan big stem cell clinic for kids for unproven infusions Read More »

Weekly reads: New FDA guidance, brains, MSCs, senescence

human mouse marmoset brain

This week marked the release of new draft FDA guidance on cell and gene therapies. Is the FDA kind of like the guidance counselor at school or more like the principal? It probably depends on many factors. I also find it funny how pretty much everyone in academia and biotech industry works to be compliant …

Weekly reads: New FDA guidance, brains, MSCs, senescence Read More »

Fact-checking stem cell therapy for autism: still a risky idea

Duke-Curemark-autism-study-pamphlet

The other day I gave a talk in part about stem cell hype and mentioned as an example how the idea of already doing stem cell therapy for autism seems so misguided to me now.  On the whole, in my view there are major downsides and risks for autistic kids whose parents are already having …

Fact-checking stem cell therapy for autism: still a risky idea Read More »

Cord conflicts at the journal Stem Cells Translational Medicine

Cord-blood-autism

The journal Stem Cells Translational Medicine has a long track record of publishing great work. I also have a lot of respect for the editors there and I’ve published there myself. But a few recent events have sparked concerns including over possible undisclosed conflicts of interest in some papers there about cord blood for autism. …

Cord conflicts at the journal Stem Cells Translational Medicine Read More »

24 cell therapy & stem cell stocks I’m following

stem cell stocks

Stem cell stocks, meaning cellular therapy biotech companies, face many challenges, but their clinical research is crucial. These biotechs have ups and downs, sometimes at the same time. This is kind of the standard of “life” as any biotech company. It is definitely the case in the volatile stem cell and cell therapy arena. Today …

24 cell therapy & stem cell stocks I’m following Read More »

Fact-checking, pros and cons of cord blood banking

cord blood banking

When my wife and I were expecting our first daughter way back in the nineties, we received a paper pamphlet about cord blood banking. Back then, I was a graduate student at UC San Diego School of Medicine working toward my Ph.D. in Molecular Pathology and my wife was in medical school at the time …

Fact-checking, pros and cons of cord blood banking Read More »